Treatment of startle and related disorders
- PMID: 37808566
- PMCID: PMC10556813
- DOI: 10.1016/j.prdoa.2023.100218
Treatment of startle and related disorders
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Matsumoto J., Hallett M. In: CD Marsden. Fahn S., editor. Movement Disorders; Butterworth, London: 1994. Startle syndromes; pp. 418–433.
-
- Bakker M.J., van Dijk J.G., van den Maagdenberg A.M., Tijssen M.A. Startle syndromes. Lancet Neurol. 2006;5(6):513–524. - PubMed
-
- Kingsmore S.F., Giros B., Suh D., Bieniarz M., Caron M.G., Seldin M.F. Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nat. Genet. 1994;7:136–141. - PubMed
-
- Goldberg M.A., Dorman J.D. Intention myoclonus: successful treatment with clonazepam. Neurology. 1976;26:24–26. - PubMed
-
- McAbee G.N. Clobazam-Clonazepam combination effective for stimulus-induced falling in Hyperekplexia. J. Child Neurol. 2015;30(1):91–92. - PubMed
LinkOut - more resources
Full Text Sources
